Influence of Pneumocystis carinii on nitrite production by rat alveolar macrophages

Journal of Eukaryotic Microbiology

Volumn 43, Issue 5, 1996, Pages 400-403

  Simonpoli, Anne Marie ^a   Rajagopalan Levasseur, Premavathy ^a   Brun Pascaud, Monique ^a   Bertrand, Guylene ^a   Pocidalo, Marie Anne ^a   Girard, Pierre Marie ^b  

^a BICHAT HOSPITAL   (France)

^b HÔPITAL ROTHSCHILD   (France)

Author keywords

IFN ; immunocompetent; immunosuppressed; in vitro; latently infected rats; lipopolysaccharide; P. carinii naive rats

Indexed keywords

ANIMALIA; PNEUMOCYSTIS CARINII;

EID: 0030248787     PISSN: 10665234     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1550-7408.1996.tb05050.x     Document Type: Article

References (26)

1. Adams, L. B., Hibbs, J. B., Jr., Taintor, R. R & Krahenbuhl, J. L. 1990 Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from L-arginine. J. Immunol., 144:2725-2729.
2. Bartlett, M. S., Queener, S F., Jay, M. A., Durkin, M. M. & Smith, J W. 1987. Improved rat model for studying Pneumocystis carinii pneumonia. J. Clin. Microbiol., 25:480-484.
3. Beckman, J. S., Beckman, T. W., Chen, J., Marshall. P. A. & Freeman. B. A. 1990. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA, 87:1620-1624.
4. Brun-Pascaud, M., Girard, P. M. & Pocidalo, J. J. 1992. Low-dose trimethoprim-sulfamethoxazole alone and in association with zidovudine for prevention and treatment of murine Pneumocystis carinii pneumonia. Antimicrob. Agents Chemother., 36:2328-2330.
5. Denis, M. 1991. Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via generation of reactive nitrogen intermediates. Cell. Immunol., 132:150-157.
6. Denis, M. 1991. Tumor necrosis factor and granulocyte-macrophage-colony-stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates. J. Leuko. Biol , 49:380-387.
7. Ding, A. H., Nathan, C. F. & Stuehr, D. J. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol., 141:2407-2412.
8. Ezekowitz, R. A. B., Williams, D. J., Koziel, H., Armstrong, M. Y. K., Warner, A., Richards, F. F. & Rose, R. M. 1991. Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor. Nature, 351:155-158.
9. Frenkel, J. K., Good, J T. & Schultz, J.A. 1966. Latent Pneumocystis infection in rats, relapse and chemotherapy. Lab. Invest., 15: 1559-1577.
10. Gosey, L. L., Howard, R. M., Witebsky, F. G., Ognibene, E P., Wu, T. C., Gill, V. J. & Mac Lowry, J. 1985. Advantages of a modified toluidine blue O stain and bronchoalveolar lavage for the diagnosis of Pneumocystis carinii pneumonia J. Clin. Microbiol., 22:803-807.
11. Granger, D. L., Hibbs, J. B., Jr., Perfect, J. R. & Durack, D. T. 1990. Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages. J. Clin. Invest., 85:264-273.
12. Green, S. J , Chen, T. Y., Crawford, R. M., Nacy, C. A., Morrison, D. C. & Meltzer, M. S 1992. Cytotoxic activity and production of toxic nitrogen oxides by macrophages treated with IFNγ and monoclonal antibodies against the 73-kDa lipopolysaccharide receptor. J. Immunol., 149-2069-2075.
13. Green, S. J., Meltzer, M. S., Hibbs, J. B., Jr, & Nacy, C. A. 1990. Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J. Immunol., 144: 278-283.
14. Green, S. J. & Nacy, C. A. 1993. Antimicrobial and immunopathologic effects of cytokine-induced nitric oxide synthesis. Curr. Opin. Infect. Dis., 6:384-396.
15. 15N) nitrate in biological fluids. Anal. Biochem., 126:131-138.
16. Hughes, T. H., McNabb, P. C., Makres, T. D. & Feldman, S. 1974. Efficacy of trimethoprim and sulfamethoxazole in the prevention and treatment of Pneumocystis carinii pneumonitis. Antimicrob. Agents Chemother., 5:289-293.
17. Masur, H. & Jones, T. C. 1978 The interaction in vitro of Pneumocystis carinii with macrophages and L cells. J. Exp. Med., 147:157-170.
18. Moncada, S. & Higgs, A. 1993. The L-arginine-nitric oxide pathway. N. Engl. J. Med., 329:2002-2012.
19. Pesanti, E. L. 1991. Interaction of cytokines and alveolar cells with Pneumocystis carinii in vitro. J. Infect. Dis., 163.611-616.
20. Sherman, M. P., Luiza Loro, M., Wong, V. Z. & Tashkin, D. P. 1991. Cytokine- and Pneumocystis carinii-induced L-arginine oxidation by murine and human pulmonary alveolar macrophages. J. Protozool., 38:234S-236S.
21. Tucker, S. B., Pierre, R. V. & Jordan, R. E. 1977. Rapid identification of monocytes in a mixed mononuclear cell preparation. J. Immunol., 14:267-269.
22. VonBerhen, L. A. & Pesanti, E. L 1978. Uptake and degradation of Pneumocystis carinii by macrophages in vitro. Am. Rev. Respir. Dis., 118:1051-1059.
23. Walzer, P. D. 1993. Pneumocystis carinii: recent advances in basic biology and their clinical application. AIDS, 7:1293-1305.
24. Walzer, P. D., Powel, R. D., Jr., Yoneda, K., Rutledge, M. E. & Milder, J. E. 1980. Growth characteristics and pathogenesis of experimental Pneumocystis carinii pneumonia. Infect. Immun., 27:928-937.
25. Yoshida, Y. & Ikai, T. 1979. Pneumocystis carinii pneumonia: epidemiology in Japan and cysts concentration method. Zbl. Bak. Hyg. I. Abt. Orig., A 244:405-410.
26. Zhang, X. & Morrison, D. C. 1993. Lipopolysaccharide-induced selective priming effects on tumor necrosis factor α and nitric oxide production in mouse peritoneal macrophages. J. Exp. Med., 177:511-516.